Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1976 Jun;33(6):584–592. doi: 10.1038/bjc.1976.95

Effect of BCG on cell-mediated cytotoxicity and serum blocking factor during growth of rat hepatoma.

M J Embleton
PMCID: PMC2025102  PMID: 181041

Abstract

Inbred rats were injected s.c. with cells of syngeneic hepatoma D23, D23 cells + BCG as a mixed inoculum, mixed inoculum one side and D23 alone contralaterally, or BCG alone. Their blood mononuclear cells were tested weekly for cytotoxicity against D23 target cells using a microcytotoxicity method and their serum was tested for blocking activity against cytotoxicity by lymph node cells from immunized rats. Tumour growth was suppressed when BCG was in contact with tumour cells but tumours grew unhindered if the BCG was given contralaterally. All rats receiving tumour cells, either alone or mixed with BCG, developed cell-mediated cytotoxicity which remained until termination at 35 days. Rats receiving BCG alone showed slight initial cytotoxicity which disappeared after 7 days. Blocking factors appeared in the serum of rats which developed growing tumours but not in rats whose tumours were suppressed by contact with BCG. Splenectomized rats did not differ markedly from intact rats in the in vitro studies or in vivo. It is concluded that development of cell-mediated immunity and blocking factors depends more upon treatment with tumour cells and the subsequent behaviour of the tumour than upon treatment with BCG per se.

Full text

PDF
584

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin R. W., Embleton M. J., Robins R. A. Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status. Int J Cancer. 1973 Jan 15;11(1):1–10. doi: 10.1002/ijc.2910110102. [DOI] [PubMed] [Google Scholar]
  2. Baldwin R. W., Pimm M. V. B.C.G. suppression of pulmonary metastases from primary rat hepatomata. Br J Cancer. 1974 Nov;30(5):473–476. doi: 10.1038/bjc.1974.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baldwin R. W., Pimm M. V. BCG immunotherapy of rat tumors of defined immunogenicity. Natl Cancer Inst Monogr. 1973 Dec;39:11–19. [PubMed] [Google Scholar]
  4. Baldwin R. W., Pimm M. V. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas. Rev Eur Etud Clin Biol. 1971 Nov;16(9):875–881. [PubMed] [Google Scholar]
  5. Baldwin R. W., Price M. R., Robins R. A. Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen. Int J Cancer. 1973 May;11(3):527–535. doi: 10.1002/ijc.2910110304. [DOI] [PubMed] [Google Scholar]
  6. Bansal S. C., Sjögren H. O. Counteractions of the blocking of cell-mediated tumor immunity by inoculation of unblocking sera and splenectomy: immunotherapeutic effects on primary polyoma tumors in rats. Int J Cancer. 1972 May 15;9(3):490–509. doi: 10.1002/ijc.2910090306. [DOI] [PubMed] [Google Scholar]
  7. Bansal S. C., Sjögren H. O. Effects of BCG on various facets of the immune response against polyoma tumors in rats. Int J Cancer. 1973 Jan 15;11(1):162–171. doi: 10.1002/ijc.2910110119. [DOI] [PubMed] [Google Scholar]
  8. Bartlett G. L., Zbar B., Rapp H. J. Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis. J Natl Cancer Inst. 1972 Jan;48(1):245–257. [PubMed] [Google Scholar]
  9. Berkelhammer J., Mastrangelo M. J., Laucius J. F., Bodurtha A. J., Prehn R. T. Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donors. Int J Cancer. 1975 Oct 15;16(4):571–578. doi: 10.1002/ijc.2910160407. [DOI] [PubMed] [Google Scholar]
  10. Bowen J. G., Robins R. A., Baldwin R. W. Serum factors modifying cell mediated immunity to rat hepatoma d23 correlated with tumour growth. Int J Cancer. 1975 Apr 15;15(4):640–650. doi: 10.1002/ijc.2910150413. [DOI] [PubMed] [Google Scholar]
  11. Chassoux D., Salomon J. C. Therapeutic effect of intratumoral injection of bcg and other substances in rats and mice. Int J Cancer. 1975 Oct 15;16(4):515–525. doi: 10.1002/ijc.2910160402. [DOI] [PubMed] [Google Scholar]
  12. Currie G. A. Effect of active immunization with irradiated tumour cells on specific serum inhibitors of cell-mediated immunity in patients with disseminated cancer. Br J Cancer. 1973 Jul;28(1):25–35. doi: 10.1038/bjc.1973.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Currie G. A., McElwain T. J. Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study. Br J Cancer. 1975 Feb;31(2):143–156. doi: 10.1038/bjc.1975.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Evans R., Alexander P. Mechanism of immunologically specific killing of tumour cells by macrophages. Nature. 1972 Mar 24;236(5343):168–170. doi: 10.1038/236168a0. [DOI] [PubMed] [Google Scholar]
  15. Moore M., Lawrence N., Nisbet N. W. Tumour inhibition mediated by BCG in immunosuppressed rats. Int J Cancer. 1975 Jun 15;15(6):897–911. doi: 10.1002/ijc.2910150605. [DOI] [PubMed] [Google Scholar]
  16. Zöller M., Dickinson A. M., Embleton M. J. Proceedings: Cell mediated immune reactions against rat tumour cells detected by in vitro microcytotoxicity assays. Br J Cancer. 1975 Aug;32(2):240–240. doi: 10.1038/bjc.1975.154. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES